Alaunos Therapeutics, Inc. Common Stock
Symbol: TCRT (NASDAQ)
2.20
▼ (-4.57%) -0.105
Company Description:
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.
Key Stats
- Today's Open: $2.31
- Today's High: $2.334
- Today's Low: $2.176
- Today's Volume: 45.20K
- Yesterday Close: $2.3
- Yesterday High: $2.32
- Yesterday Low: $2.1707
- Yesterday Volume: 27.61K
- Last Min Volume: 1
- Last Min High: $2.195
- Last Min Low: $2.195
- Last Min VWAP: $2.195
Company Profile
- Name: Alaunos Therapeutics, Inc. Common Stock
- Website: https://www.alaunos.com
- Listed Date: 2005-08-24
- Location: HOUSTON, TX
- Market Status: Active
- CIK Number: 0001107421
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $4.83M
- Round Lot: 100
- Outstanding Shares: 2.21M
- Asset Type: CS
RECENT FILINGS FOR TCRT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-09 | S-3/A | View |
| 2025-09-05 | SCHEDULE 13D/A | View |
| 2025-09-04 | SCHEDULE 13G | View |
| 2025-08-21 | S-3 | View |
| 2025-08-20 | 4 | View |
| 2025-08-20 | 4 | View |
| 2025-08-20 | 8-K | View |
| 2025-08-14 | 10-Q | View |
| 2025-07-22 | 8-K | View |
| 2025-07-17 | 4 | View |
| 2025-07-17 | 3 | View |
| 2025-07-17 | 8-K | View |
| 2025-07-10 | 8-K | View |
| 2025-07-07 | 4 | View |
| 2025-07-07 | 4 | View |
| 2025-07-07 | 4 | View |
| 2025-07-02 | 8-K | View |
| 2025-07-01 | SCHEDULE 13D | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
Latest News on TCRT